TECH

BIO-TECHNE CORP

Healthcare | Mid Cap

$0.40

EPS Forecast

$292.3

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncNVAXNovavax IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen CorpMRNAModerna Inc